The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
Open accessAbstract
Aims To establish a unified working diagnostic tool for the metabolic syndrome (MetS) that is convenient to use in clinical practice and that can be used world‐wide so that data from different countries can be compared. An additional aim was to highlight areas where more research into the MetS is needed. Participants The International Diabetes Federation (IDF) convened a workshop held 12–14 May 2004 in London, UK. The 21 participants included experts in the fields of diabetes, public health, epidemiology, lipidology, genetics, metabolism, nutrition and cardiology. There were participants from each of the five continents as well as from the World Health Organization (WHO) and the National Cholesterol Education Program—Third Adult Treatment Panel (ATP III). The workshop was sponsored by an educational grant from AstraZeneca Pharmaceuticals. Consensus process The consensus statement emerged following detailed discussions at the IDF workshop. After the workshop, a writing group produced a consensus statement which was reviewed and approved by all participants. Conclusions The IDF has produced a new set of criteria for use both epidemiologically and in clinical practice world‐wide with the aim of identifying people with the MetS to clarify the nature of the syndrome and to focus therapeutic strategies to reduce the long‐term risk of cardiovascular disease. Guidance is included on how to compensate for differences in waist circumference and in regional adipose tissue distribution between different populations. The IDF has also produced recommendations for additional criteria that should be included when studying the MetS for research purposes. Finally, the IDF has identified areas where more studies are currently needed; these include research into the aetiology of the syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Quite independent of this, several separate and conflicting components and diagnostic criteria for the Metabolic Syndrome had been proposed by different organizations and individuals over past decades.”
From The Circadian Syndrome: is the Metabolic Syndrome and much more! (2019) · cites this paper as [44]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Self-citationRole of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Flagged first, then by citations
Research works printed but not linked: 8
- Kylin E, 1923, Zentralblatt Fuer Innere Med, 44, 105
- Vague J, 1947, Presse Medl, 53, 339
- World Health Organization., 1999, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications.
- American College of Endocrinology Task Force on the Insulin Resistance Syndrome., 2003, Endocr Pract, 9, 236
- Nesto RW, 2003, Rev Cardiovasc Med, 4, S11
- Zhou BF, 2002, Biomed Environ Sci, 15, 83
- Balkau B, 2002, Diabet Metab, 28, 364
- Cameron AJ, 2003, Atherosclerosis, 46, A3068
Cited by
Sorted by citations
Items 101–104 of 104
Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women
Seon, M. J., Hwang, S. Y., Son, Y., Song, J., & Kim, O. Y. (2021) · Nutrients · doi:10.3390/nu13030865 · Cited by 21
Prokudina, E. S., Maslov, L. N., Ivanov, V. V., Bespalova, I. D., Pismennyi, D. S., & Voronkov, N. S. (2017) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn798 · Cited by 17
Barros, Z. M., de Alencar Ximenes, R. A., Miranda-Filho, D. B., de Albuquerque, M. D. F. P. M., Melo, H. R. L., Carvalho, É. H., Gelenske, T., Diniz, G., & Bandeira, F. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0100 · Cited by 16
Insulin sensitivity and pancreatic β-cell function in Ecuadorian women with Turner syndrome
Álvarez-Nava, F., Bastidas, D., Racines-Orbe, M., & Guarderas, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00482 · Cited by 11
Metadata
- Authors
- Alberti, K. G. M. M., Zimmet, P., & Shaw, J.
- Affiliations
- St Mary's Hospital (GB)
- Corresponding author
- Alberti, K. G. M. M.
- ORCID
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2006-04-20
- Volume
- 23
- Issue
- 5
- Pages
- 469-480
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2130717716
- Cited by
- 6,597
- References
- 77
- Citations by year
- 2026: 227 · 2025: 319 · 2024: 371 · 2023: 375 · 2022: 360 · 2021: 420 · 2020: 406 · 2019: 338 · 2018: 370 · 2017: 347 · 2016: 317 · 2015: 346 · 2014: 402 · 2013: 369 · 2012: 334
- FWCI
- 151.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- AstraZeneca
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- metabolic syndrome, diagnostic criteria, International Diabetes Federation, consensus statement, waist circumference, body fat distribution, cardiovascular risk
- MeSH terms
- Adipose Tissue, Adult, Female, Humans, Hypertension, Insulin Resistance, International Cooperation, Male, Obesity, Societies, Medical, Metabolic Syndrome, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
